Tiziana Life Sciences (TILS) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free TILS Stock Alerts GBX 58.50 +4.50 (+8.33%) (As of 10/20/2021) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTiziana Life Sciences (LON:TILS) Shares Cross Below 200-Day Moving Average of $58.50americanbankingnews.com - April 17 at 4:08 AMTiziana Life Sciences to present immunotherapy updates at...Tiziana Life Sciences to present immunotherapy updates at Webull...proactiveinvestors.com - December 6 at 10:49 PMTiziana : FDA Allows Multiple Sclerosis Patients To Take Home & Self-administer Intranasal Foralumabmarkets.businessinsider.com - October 18 at 10:56 AMTiziana Life Sciences: FDA signs off on home-based protocol fo MS treatmentproactiveinvestors.com - October 18 at 10:56 AMTiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumabmarkets.businessinsider.com - October 16 at 7:56 AMTiziana Life Sciences reports six-month PET scan results for MS patientsproactiveinvestors.com - October 13 at 10:27 AMTiziana Life Sciences Ltd (0RP)uk.investing.com - September 26 at 3:01 PMTiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosistmcnet.com - September 26 at 8:24 AMTiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunologytechnews.tmcnet.com - August 23 at 7:44 AMTiziana Life Sciences’ stock soars 54% premarket after FDA clear path for trial of intranasal treatment for Alzheimer’s diseasemsn.com - August 15 at 6:29 PMTiziana Life Sciences To Submit Alzheimer's IND In Q2 2023, Seeks $3 Million From An Alzheimer's Foundation To Support Phase 2a Trialbenzinga.com - April 21 at 1:18 PMTiziana Life Sciences CEO purchases sharesseekingalpha.com - March 19 at 7:12 PMTiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officerfinanznachrichten.de - September 25 at 4:32 PMTiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officerbenzinga.com - September 9 at 10:15 AMHarry Styles and Olivia Wilde Hit Their First Red Carpet Together Amid 'Don't Worry Darling' Dramayahoo.com - September 6 at 10:40 PMTiziana Life Sciences' half-term report reveals it has made progress on all frontsproactiveinvestors.com - July 2 at 12:02 AMTiziana Life Sciences Ltd. Receives Nasdaq Deficiency Noticefinance.yahoo.com - June 17 at 6:51 PMTiziana Life Sciencesfool.co.uk - June 9 at 6:36 AMProactive news headlines including NEO Battery Materials, New Age Metals, Belmont Resources, Ridgeline Minerals, Electra Battery Materials, Tiziana Life Sciences and Aben Resourcesbenzinga.com - June 8 at 2:14 PMTiziana Life Sciences Shares Jump After Multiple Sclerosis Data From Second Patientbenzinga.com - June 8 at 12:46 PMAdvan Co Ltd (7463)investing.com - June 7 at 9:49 PMSilvio Berlusconi, 85, 'used women as sex slaves' at his infamous 'bunga bunga' parties during time as Italian PM and was a 'sultan in his own harem', court hearsdailymail.co.uk - May 21 at 10:47 PMProactive news headlines including SPYR, Predictmedix, Bridgeline Digital, Tiziana Life Sciences, GameSquare and Empower Clinicsfinancialpost.com - April 5 at 3:24 PMTiziana Life Sciences: Multiple Sclerosis single studyproactiveinvestors.com - March 24 at 10:58 PMTiziana Life Sciences: Method of therapy delivery gives firm 'a novel market position'proactiveinvestors.com - March 24 at 10:58 PM2022 update: US listing and fresh data emergingproactiveinvestors.com.au - January 28 at 11:53 PMMaxCyte expects improved full-year revenue on organic growthlse.co.uk - January 26 at 7:37 PMProactive news headlines including Starton Therapeutics, Safe-T Group, Genprex, Hawkmoon Resources, District Metals and Tiziana Life Sciencesbenzinga.com - January 10 at 2:47 PMTiziana Life Sciences Plc Share Chatlse.co.uk - October 28 at 1:52 PMTiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of ...apnews.com - October 20 at 8:42 AMTiziana Life Sciences Plc: Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capitalfinanznachrichten.de - October 19 at 9:34 AMTiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capitalfinance.yahoo.com - October 19 at 9:34 AMTiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021finance.yahoo.com - September 24 at 1:03 PMTiziana Life Sciences: A different approach, tackling disease using a safe, nasal and oral antibodyproactiveinvestors.com - September 22 at 7:43 AMTiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatmentfinance.yahoo.com - September 7 at 3:09 AMTiziana Life Sciences plc Posting of Scheme Document and Notice of Meetingsfinance.yahoo.com - September 3 at 3:26 AMTLSA: Foralumab Now in CAR Tfinance.yahoo.com - September 2 at 12:11 PMTiziana Life Sciences Plc: Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisationfinanznachrichten.de - August 21 at 2:53 AMTiziana Life Sciences plc files scheme of...benzinga.com - August 20 at 4:45 PMTiziana Life Sciences set for Nasdaq moveproactiveinvestors.com - August 20 at 4:45 PMTiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazilfinance.yahoo.com - August 17 at 3:16 PMTiziana Life Science - Second Price Monitoring Extnproactiveinvestors.com.au - August 5 at 11:21 PMTiziana Life Science - Price Monitoring Extensionproactiveinvestors.com - August 5 at 11:21 PM Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. TILS Media Mentions By Week TILS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TILS News Sentiment▼0.670.44▲Average Medical News Sentiment TILS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TILS Articles This Week▼00▲TILS Articles Average Week Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FUM News Today FARN News Today SCLP News Today ETX News Today AVCT News Today POLB News Today HVO News Today ARIX News Today REDX News Today AREC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:TILS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
